Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DXR Daxor	$11.00 +1.5%	$9.81	$6.55 ▼ $11.38	$53.21M	-0.13	79,638 shs	3,712 shs
ICCM IceCure Medical	$0.88 +0.8%	$0.97	$0.48 ▼ $1.66	$51.81M	0.32	2.78 million shs	364,139 shs
MDAI Spectral AI	$2.09 +3.5%	$2.42	$0.82 ▼ $3.25	$52.91M	0.9	382,353 shs	267,721 shs
VAPO Vapotherm	$2.17	$2.16	$0.70 ▼ $3.44	$13.58M	-1.11	N/A	51,531 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DXR Daxor	0.00%	+3.77%	+10.00%	+42.12%	+29.87%
ICCM IceCure Medical	0.00%	-1.73%	-10.38%	-16.72%	+18.15%
MDAI Spectral AI	0.00%	-0.95%	-22.88%	+43.15%	+29.01%
VAPO Vapotherm	0.00%	0.00%	0.00%	0.00%	+0.59%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DXR Daxor	4.3715 of 5 stars	3.5	5.0	0.0	0.0	3.9	1.7	0.0
ICCM IceCure Medical	1.8816 of 5 stars	3.5	2.0	0.0	0.0	2.2	0.0	0.6
MDAI Spectral AI	3.2125 of 5 stars	3.5	4.0	0.0	0.0	2.6	3.3	0.0
VAPO Vapotherm	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DXR Daxor	3.00	Buy	$25.00	127.27% Upside
ICCM IceCure Medical	3.00	Buy	$2.39	170.16% Upside
MDAI Spectral AI	3.00	Buy	$3.50	67.46% Upside
VAPO Vapotherm	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest VAPO, MDAI, DXR, and ICCM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/15/2025	ICCM IceCure Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$2.50 ➝ $2.00
8/15/2025	ICCM IceCure Medical	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/13/2025	ICCM IceCure Medical	Brookline Capital Management Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
8/13/2025	ICCM IceCure Medical	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$2.77
5/29/2025	ICCM IceCure Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$2.50

(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DXR Daxor	N/A	N/A	N/A	N/A	N/A	N/A
ICCM IceCure Medical	$3.29M	15.75	N/A	N/A	$0.05 per share	17.66
MDAI Spectral AI	$29.58M	1.79	N/A	N/A	($0.36) per share	-5.81
VAPO Vapotherm	$68.67M	0.20	N/A	N/A	($9.01) per share	-0.24

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DXR Daxor	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ICCM IceCure Medical	-$15.32M	-$0.16	N/A	N/A	N/A	-317.62%	-136.96%	-71.46%	N/A
MDAI Spectral AI	-$15.31M	-$0.69	N/A	N/A	N/A	-51.97%	N/A	-8.69%	11/5/2025 (Estimated)
VAPO Vapotherm	-$58.19M	-$8.51	N/A	∞	N/A	-76.74%	N/A	-68.08%	N/A

Latest VAPO, MDAI, DXR, and ICCM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	ICCM IceCure Medical	-$0.06	$0.06	+$0.12	$0.06	$0.90 million	$0.66 million
8/12/2025	Q2 2025	MDAI Spectral AI	-$0.07	-$0.10	-$0.03	-$0.31	$5.44 million	$5.07 million
5/28/2025	Q1 2025	ICCM IceCure Medical	-$0.08	-$0.06	+$0.02	-$0.06	$0.75 million	$0.73 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DXR Daxor	N/A	N/A	N/A	N/A	N/A
ICCM IceCure Medical	N/A	N/A	N/A	N/A	N/A
MDAI Spectral AI	N/A	N/A	N/A	N/A	N/A
VAPO Vapotherm	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DXR Daxor	N/A	N/A	N/A
ICCM IceCure Medical	0.02	1.18	0.88
MDAI Spectral AI	N/A	0.87	0.84
VAPO Vapotherm	N/A	0.25	0.09

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DXR Daxor	1.34%
ICCM IceCure Medical	0.62%
MDAI Spectral AI	67.08%
VAPO Vapotherm	43.08%

Insider Ownership

Company	Insider Ownership
DXR Daxor	59.50%
ICCM IceCure Medical	2.44%
MDAI Spectral AI	30.70%
VAPO Vapotherm	15.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DXR Daxor	37	4.84 million	1.96 million	Not Optionable
ICCM IceCure Medical	60	58.70 million	57.27 million	Not Optionable
MDAI Spectral AI	83	25.32 million	17.55 million	Not Optionable
VAPO Vapotherm	290	6.26 million	5.27 million	No Data

VAPO, MDAI, DXR, and ICCM Headlines

Recent News About These Companies

New Study Confirms Vapotherm's Unicorn™ Cannula Provides Comparable Efficacy at Lower Flow Rates

May 20, 2025 | finance.yahoo.com

Global High-Flow Oxygen Therapy Devices Market Set to Reach USD 1,567.2 Million by 2033 Amid Rising Demand for Respiratory Care Solutions | FMI

October 25, 2024 | fmiblog.comF

Global Active Humidifier Devices Market Projects Modest Decline Amid Shifting Respiratory Care Landscape | FMI

October 25, 2024 | fmiblog.comF

Decline Looms Over Global High Flow Nasal Cannula Market to reach USD 1,063.0 Million by 2034: A Call for Innovation and Adaptation | FMI

October 21, 2024 | fmiblog.comF

Global Endobronchial Valves Market Expected to Experience Strong Growth by 2031 | Exactitude Consultancy

September 24, 2024 | finance.yahoo.com

Vapotherm, Inc.: Vapotherm Announces Closing of Merger

September 20, 2024 | finanznachrichten.de

Vapotherm Announces Closing of Merger

September 20, 2024 | prnewswire.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VAPO, SGE, RPHM, SQSP on Behalf of Shareholders

August 30, 2024 | stockhouse.com

VAPO Stock Earnings: Vapotherm Reported Results for Q2 2024

August 13, 2024 | msn.com

Vapotherm Reports Second Quarter 2024 Financial Results

August 12, 2024 | prnewswire.com

PLPL Plandaí Biotechnology, Inc.

July 28, 2024 | seekingalpha.com

VA20.SG,0P0001F4D7,0 (VA20.SG)

July 23, 2024 | finance.yahoo.com

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Vapotherm, Inc. - VAPO

July 9, 2024 | prnewswire.com

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Vapotherm, Inc. – VAPO

July 8, 2024 | globenewswire.com

The Schall Law Firm Is Performing A Scrutiny Into Vapotherm Inc And Welcomes Investors Of VAPO To Engage

July 1, 2024 | accesswire.comA

The Schall Law Firm Is Carrying Out An Inquiry Into Vapotherm Inc And Requests Investors Of VAPO To Be Part Of It

June 30, 2024 | accesswire.comA

The Schall Law Firm Is Undertaking An Investigation Into Vapotherm Inc And Invites Investors Of VAPO To Join

June 29, 2024 | accesswire.comA

The Schall Law Firm Is Leading An Investigation Into Vapotherm Inc And Invites Investors Of VAPO To Join

June 28, 2024 | accesswire.comA

The Schall Law Firm Is Conducting A Probe Into Vapotherm Inc And Encourages VAPO Investors To Participate

June 27, 2024 | accesswire.comA

The Schall Law Firm Is Conducting A Probe Into Vapotherm Inc And Encourages Investors Of VAPO To Participate

June 26, 2024 | accesswire.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

VAPO, MDAI, DXR, and ICCM Company Descriptions

Daxor NASDAQ:DXR

$11.00 +0.16 (+1.48%)

As of 08/22/2025 02:28 PM Eastern

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

IceCure Medical NASDAQ:ICCM

$0.88 +0.01 (+0.82%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$0.89 +0.01 (+0.59%)

As of 08/22/2025 06:30 PM Eastern

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Spectral AI NASDAQ:MDAI

$2.09 +0.07 (+3.47%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$2.09 0.00 (0.00%)

As of 08/22/2025 07:48 PM Eastern

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

Vapotherm NYSE:VAPO

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time